Instructions for Suprima-Lor (Dichlorobenzyl alcohol, Amylmetacresol) lozenge tablet
Form of release, packaging and composition of the drug Suprima-Lor
Yellow (pineapple) absorption pills, round, with pineapple odor; allowed irregularity of coloring, the presence of air bubbles in the caramel mass and slight irregularity of the surface and edges of the pills; possible appearance of white plaque.
1 tab
2,4-dichlorobenzyl alcohol 1.2 mg
amylmethacresol 600 ug
Accessories: sugar S/30 base, dextrose 84%, anhydrous citric acid, menthol, sunset yellow dye, quinoline yellow dye, pineapple fragrance.
4 pcs - aluminum strips (4) - cardboard packs.
Suction tablets (raspberry) are red-raspberry in color, round, with raspberry smell; irregularity of coloring, presence of air bubbles in caramel mass and slight irregularity of the surface and edges of the tablets are allowed; possible appearance of white plaque.
Pharmacological effect Suprima-Lor
Suprima-LOR is an innovative antiseptic drug developed specifically for local use in the oral and pharyngeal cavity. Its main action is in the fight against microbes, which is due to the activity of the drug against gram-positive and gram-negative microorganisms. The unique effectiveness of Suprima-ENT is ensured by the presence of two antibacterial components with a broad spectrum of action.
Pharmacokinetics
Suprima-ENT has low systemic absorption and pharmacokinetic data are not available. This guarantees the safety and efficacy of the drug when used in local therapy.
Suprim-LOR Testimony
The drug Suprima-ENT is recommended for symptomatic treatment of infectious-inflammatory diseases of the mouth and pharynx. Due to its antimicrobial properties, it provides effective mitigation of the symptoms of various infectious processes in these areas.
